RUBELLA IGM - INVIMA Registration 2cf2f901f2838bbdb524ee47de6cc0c4
Access comprehensive regulatory information for RUBELLA IGM (RUBELLA IGM) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 2cf2f901f2838bbdb524ee47de6cc0c4 and manufactured by SIEMENS HEALTHCARE S.A.S.. The device was registered on March 27, 2029.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
PARA EL DIAGNÓSTICO IN VITRO USADO CON LOS _x000D_ ANALIZADORES IMMULITE, IMMULITE 1000 E IMMULITE 2000_x000D_ — PARA LA DETECCIÓN CUALITATIVA DE ANTICUERPOS IGM_x000D_ FRENTE AL VIRUS DE LA RUBEOLA EN SUERO O PLASMA _x000D_ (EDTA O EPARINIZADO), COMO AYUDA EN LA _x000D_ DETERMINACIÓN DE LA INFECCIÓN DE LA FASE AGUDA O _x000D_ RECIENTE DE RUBEOLA, PRINCIPALMENTE EN MUJERES EN_x000D_ EDAD FERTIL. O RECIENNACIDOS.
FOR IN VITRO DIAGNOSTICS USED WITH _x000D_ IMMULITE, IMMULITE 1000 AND IMMULITE 2000_x000D_ ANALYZERS — FOR THE QUALITATIVE DETECTION OF ANTIBODIES IGM_x000D_ AGAINST RUBELLA VIRUS IN SERUM OR PLASMA _x000D_ (EDTA OR EPARINIZED), AS AN AID IN _x000D_ DETERMINATION OF ACUTE PHASE INFECTION OR _x000D_ RECENT RUBELLA, MAINLY IN WOMEN EN_x000D_ FERTILE AGE. OR NEWBORNS.